About: K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2000 (uk) im November 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2000 (ast) scientific article published on 01 November 2000 (en)
publication date	wds:Q73259679-90762DF7-9002-4F70-BA50-C3E463993D9D
publication date	2000-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73259679-4BBE067D-EE8B-4BCE-A393-BF15128D8C7E
language of work or name	English
author name string	wds:Q73259679-0A5D9105-88DF-4E22-9F46-2C1BB2F177A1 wds:Q73259679-384EA65D-ADFB-49A4-AACC-B25895361043 wds:Q73259679-4B7ED59D-1887-4226-959A-E95A503A9B0D wds:Q73259679-61C07001-B50C-433B-96D3-F77024193F6B wds:Q73259679-6AA07F1F-53AE-4E89-96EB-C21789DBEF45 wds:Q73259679-9E71C907-AB7E-485F-B228-5186A1BC3FBB wds:Q73259679-AE9281DE-1F41-494B-89D2-B330DAE3F81B wds:Q73259679-B950916B-7A25-4075-8246-44630A5C59B5 wds:Q73259679-BF24E087-C115-42DA-8AB4-093A71938467
author name string	F Campbell J D Evans A Andrén-Sandberg S Dawiskiba N Lemoine P Ghaneh R Skar A Kawesha D Ograed
rdfs:label	K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (en) K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (nl)
skos:prefLabel	K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (en) K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (nl)
name	K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (en) K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (nl)
author	wds:Q73259679-0E649EC5-3AF4-493F-8C7D-1084EC8736E8
author	John P Neoptolemos
title	wds:Q73259679-C058268A-7D77-4FE9-91F8-030022FD8B9B
title	K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma (en)
page(s)	wds:Q73259679-6955D646-F293-4C3B-80C2-68138CD81F37
page(s)	469-474
instance of	wds:Q73259679-05220620-95D2-46F1-9171-5357B2E869E5
instance of	scholarly article
main subject	wds:Q73259679-3B74BD48-ECA2-4C69-8E0F-3219DE054FFE wds:Q73259679-6EDC9FE7-1DF1-4CBB-9E6B-22239811C7E8 wds:Q73259679-AC5FC1AF-3DD9-425F-BD88-D74544D47E4F
main subject	invasive ductal carcinoma pancreatic ductal carcinoma pancreatic ductal adenocarcinoma
PubMed ID	wds:Q73259679-4A0B30CB-F23B-4195-9D52-186614FCB21A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11102889
PubMed ID	11102889
published in	wds:Q73259679-F6EFCC30-D2C2-43E3-94AD-2CF37AB22616
published in	International Journal of Cancer
issue	wds:Q73259679-3827313E-9D36-481C-8589-EED42B2B05BF
volume	wds:Q73259679-E580D771-850A-4FE3-9B71-A7C512EFD7DB
issue	6
volume	89
DOI	wds:Q73259679-464EA2AF-881C-4FBB-9752-8C54D726A500
DOI	http://dx.doi.org/10.1002/1097-0215(20001120)89:6%3C469::AID-IJC1%3E3.0.CO;2-L
DOI	10.1002/1097-0215(20001120)89:6<469::AID-IJC1>3.0.CO;2-L
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73259679
is cites work of	PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications. Tailoring to RB: tumour suppressor status and therapeutic response Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes Advances in pancreatic cancer detection Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer Ras in cancer and developmental diseases The genetics of pancreatic cancer. Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Plumbagin, isolated from Plumbago zeylanica, induces cell death through apoptosis in human pancreatic cancer cells Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition p53 protein expression and CA19.9 values in differential cytological diagnosis of pancreatic cancer complicated with chronic pancreatitis and chronic pancreatitis Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection. High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region. The molecular targets for the diagnosis and treatment of pancreatic cancer Trials of gene therapy for pancreatic carcinoma Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers Somatic mutations in exocrine pancreatic tumors: association with patient survival Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review. KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression Prognostic value of p27 kip1 expression in adenocarcinoma of the pancreatic head region Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater. Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations. Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency TGF-beta and p53 staining in CT-guided and endoscopic ultrasound fine-needle aspirates of pancreatic adenocarcinoma. Gene therapy for pancreatic cancer--current and prospective strategies.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software